The reiteration of a Buy rating and maintenance of a $50 price target by a reputable analyst like Robyn Karnauskas from Truist Securities could instill confidence among investors and potentially lead to a positive short-term impact on Arcus Biosciences' stock price. Analyst ratings, especially from well-regarded financial institutions, can significantly influence investor sentiment and stock prices.